Octreotide (as acetate)
Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about Sandostatin LAR.
The information in this leaflet was last updated on the date listed on the final page.
More recent information on the medicine may be available.
You should ensure that you speak to your pharmacist or doctor to obtain the most up
to date information on the medicine. You can also download the most up to date leaflet
Those updates may contain important information about the medicine and its use of
which you should be aware.
It does not contain all the available information. It does not take the place of talking
to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you having
Sandostatin LAR against the benefits they expect it will give you.
If you have any concerns about having this medicine, ask your doctor or pharmacist.
Keep this leaflet.
You may need to read it again.
What Sandostatin LAR is used for
Sandostatin LAR is a long acting form of Sandostatin injection. It is injected into
the buttocks once every 4 weeks, instead of having frequent injections of the short-acting
Sandostatin under the skin.
Sandostatin LAR is used to treat acromegaly
In people with acromegaly the body makes too much growth hormone which controls the
growth of tissues, organs and bones. Too much growth hormone leads to enlargement
of the bones, especially of the hands and feet. Other symptoms include headaches,
increased sweating, tiredness, numbness of the hands and feet, pain and stiffness
in the joints and loss of sexual function. By blocking the excess growth hormone,
Sandostatin LAR can relieve many of these symptoms.
Sandostatin LAR is used to relieve symptoms of certain types of cancer such as carcinoid
tumour and VIPoma.
By blocking hormones that are over-produced in these conditions, Sandostatin LAR can
relieve symptoms such as flushing of the skin and severe diarrhoea.
Sandostatin LAR contains octreotide, a man-made medicine derived from somatostatin.
Somatostatin is a substance found in the human body which controls the effects of
certain hormones such as insulin and growth hormone. Sandostatin LAR is used instead
of somatostatin because its effects are stronger and last longer.
Sandostatin LAR is used to treat advanced neuroendocrine tumours located in the gut
(eg appendix, small intestine or colon).
Neuroendocrine tumours are rare tumours which can be found in different parts of the
body. Sandostatin LAR is also used to control the growth of these tumours, when they
are located in the gut (eg appendix, small intestine or colon).
Ask your doctor if you have any questions about why Sandostatin LAR has been prescribed
Your doctor may have prescribed this medicine for another reason.
This medicine is only available with a doctor's prescription. It is not addictive.
There is very little information on the use of this medicine in children.
Before you have Sandostatin LAR
When you must not have it
Do not have Sandostatin LAR if you have an allergy to:
octreotide (the active ingredient in Sandostatin LAR) or any of the other ingredients
listed at the end of this leaflet.
Some of the symptoms of an allergic reaction may include shortness of breath, wheezing
or difficulty breathing; swelling of the face, lips, tongue or other parts of the
body; rash, itching or hives on the skin.
Do not have Sandostatin LAR after the expiry date printed on the pack or if the packaging
is torn or shows signs of tampering.
In that case, return it to your pharmacist.
Before you have it
Tell your doctor if you have any of the following medical conditions:
gallstones now or in the past
problems with your blood sugar levels, either too high (diabetes) or too low (hypoglycaemia)
problems with your liver
a history of vitamin B12 deprivation
problems with your blood pressure
problems with your thyroid.
Your doctor may want to take special precautions if you have any of these conditions.
Tell your doctor if you are taking other medicines to control blood pressure (beta-blockers
or calcium channel blockers) or agents to control fluid and electrolyte balance.
Dose adjustment may be necessary.
Tell your doctor if you are pregnant or intend to become pregnant or wish to breast-feed
There is not much information on the use of Sandostatin LAR during pregnancy or breast-feeding.
If it is necessary for you to have this medicine, your doctor will discuss with you
the benefits and risks involved. They may recommend that you use a method of contraception
to prevent pregnancy during your treatment. It is not known if Sandostatin LAR passes
into breast milk. Breastfeeding is not recommended during treatment with Sandostatin
If you have not told your doctor about any of these things, tell him/her before you
have Sandostatin LAR.
Taking other medicines
Tell your doctor if you are taking any other medicines, including any that you buy
without a prescription from a pharmacy, supermarket or health food shop.
Some medicines and Sandostatin LAR may interfere with each other. Some of these medicines
bromocriptine, a medicine which is also used to treat acromegaly
medicines for diabetes
cimetidine, a medicine for ulcers
cyclosporin, a medicine used to suppress the immune system
quinidine, a medicine used to prevent irregular heartbeats
medicines to control blood pressure (beta-blockers or calcium channel blockers)
agents to control fluid and electrolyte balance
You may need to take different amounts of your medicines or you may need to take different
Your doctor and pharmacist have more information on medicines to be careful with or
avoid while having Sandostatin LAR.
How Sandostatin LAR is given
Your doctor or nurse will inject Sandostatin LAR into your buttocks.
How much is given
The usual starting dose of Sandostatin LAR is 20 mg, injected every 4 weeks. After
about 3 months, the dose may be lowered to 10 mg or increased to 30 mg depending on
how you respond to it.
Depending on your condition you may also need to continue injecting short-acting Sandostatin
under the skin for about 2 weeks after your first injection of Sandostatin LAR. Your
doctor will tell you if this is the case.
If you receive Sandostatin LAR for the treatment of neuroendocrine tumours located
in the gut, the usual dose is 30 mg every 4 weeks. Your doctor will decide how long
you should be treated with Sandostatin LAR.
If you forget to have it
If you forget to have your injection, have it as soon as you remember and then go
back to your normal schedule.
It will not do any harm if your dose is a few days late but some of your symptoms
may come back temporarily until you get back on schedule.
If you are given too much (Overdose)
Tell your doctor if you notice any of the following signs that the dose of Sandostatin
LAR is too high.
Some of the symptoms of an Sandostatin LAR overdose may include hot flushes, fatigue,
depression (sad mood), anxiety, lack of concentration and needing to pass water more
frequently than usual.
If you are taking short acting Sandostatin injected under the skin, overdose symptoms
may include changes in heart-beat, dizziness, light headedness, severe radiating chest
pain, change in attention, uncoordinated movement, pain under the rib cage (right
side), distended stomach, yellowing of the skin and eyes, fever, severe upper stomach
pain with nausea and vomiting, diarrhoea, weakness, feeling lethargic, weight loss,
stomach pain and discomfort, brown coloured urine and clay-coloured stools, nausea,
No life-threatening reactions have been reported after an overdose of this medicine.
While you are having Sandostatin LAR
Things you must do
Keep all of your doctor's appointments so that your progress can be checked.
If you must have this medicine for a long time, your doctor may want to check your
blood sugar, gallbladder, thyroid and liver function from time to time to prevent
unwanted side effects from happening.
If your doctor recommends it, make sure you use a method of contraception to prevent
pregnancy during your treatment. Tell your doctor if you become pregnant while you
are receiving this medicine.
If you are about to be started on any new medicine, remind your doctor and pharmacist
that you are having Sandostatin LAR.
Tell any other doctor, dentist or pharmacist who treats you that you are having Sandostatin
Things you must not do
Do not give this medicine to anyone else, even if their symptoms seem to be the same
Do not use it to treat any other complaints unless your doctor tells you to.
Things to be careful of
Be careful driving, operating machinery or doing jobs that require you to be alert
until you know how Sandostatin LAR affects you.
This medicine may cause dizziness, lightheadedness or weakness in some people. If
you have any of these symptoms, do not drive or do anything else that could be dangerous.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you
are having Sandostatin LAR.
All medicines can cause side effects. Sometimes they are serious, but most of the
time they are not. You may need medical treatment if you get some of the side effects.
Do not be alarmed by this list of possible side effects. You may not experience any
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor immediately if you notice:
signs of allergy such as rash, itching or hives on the skin; swelling of the face,
lips, tongue or other part of the body; shortness of breath, wheezing or troubled
severe pain, tenderness or swelling in the stomach or abdomen, which may be accompanied
by fever, nausea and vomiting, yellowing of the skin and eyes, loss of appetite, generally
feeling unwell, itching, light coloured urine (symptoms of a possible problem with
your liver, pancreas or gall bladder)
symptoms of low blood glucose (hypoglycaemia), including sweating, trembling, dizziness,
weakness, hunger, palpitations (feeling of fast or irregular heartbeat) and fatigue
symptoms of high blood glucose (hyperglycaemia), including lethargy or tiredness,
headache, thirst, passing large amounts of urine, and blurred vision
symptoms of changes in the activity of the thyroid gland (hyper or hypothyroidism)
including changes in heart rate, appetites or weight, tiredness, feeling cold or sweating
too much, anxiety or swelling at the front of the neck.
unusually slow or fast heartbeat.
thirst, low urine output, dark urine, dry flushed skin
increased bleeding or bruising (could be low level of platelets in blood).
Tell your doctor if you notice any of the following side effects and they worry you:
pain, irritation, redness, rash or swelling at the injection site
loss of appetite
indigestion, nausea or vomiting
feeling of bloating or wind
constipation, diarrhoea or other change in bowel motions
temporary hair loss
changes in the rhythm of your heartbeat
shortness of breath
Tell your doctor if you notice anything else that is making you feel unwell.
Other side effects not listed above may happen in some people.
After using Sandostatin LAR
If you have to store Sandostatin LAR at home:
Keep the vials in the original container until it is time to use them.
If you are storing the vials for longer than one day, keep them in the refrigerator
at 2°C to 8°C. Do not freeze them.
You can remove Sandostatin LAR from the fridge and store it below 25°C on the day
of injection but it must be kept in the original outer carton to protect it from light.
The suspension must only be prepared immediately prior to injection.
Sandostatin LAR carton contents should reach room temperature (20°C to 25°C) before
preparation. A minimum of 30 minutes is required.
If any vials have been left out of the fridge for longer than one day (24 hours),
do not use them.
The reconstituted suspension contains no preservative. This medicine is for single
use in one patient only. Discard any residue.
Keep the medicine where children cannot reach it.
If your doctor stops your treatment with this medicine or you find that the expiry
date has passed or the vials have been left out of the fridge for too long, ask your
pharmacist what to do with any medicine you have left over.
What it looks like
Sandostatin LAR is a white to white with yellowish tint powder packed in a glass vial.
The diluent is a clear, colourless to slightly yellow or brown solution. Each box
of Sandostatin LAR contains one vial of powder, a glass syringe of diluent to mix
with the powder, a vial adaptor and safety injection needle.
Sandostatin LAR vials contain 10 mg, 20 mg or 30 mg of the active ingredient, octreotide
(as acetate). They also contain:
The solution in the syringe contains:
water for injections
Sandostatin LAR is supplied in Australia by:
NOVARTIS Pharmaceuticals Australia Pty Limited
ABN 18 004 244 160
54 Waterloo Road
Macquarie Park NSW 2113
Web site: www.novartis.com.au
®= Registered Trademark
This leaflet was prepared in
Australian Registration Numbers
Sandostatin LAR 10 mg vial
AUST R 227962
Sandostatin LAR 20 mg vial
AUST R 227963
Sandostatin LAR 30 mg vial
AUST R 227964
Internal Document Code:
(smsL240119c.doc) based on PI (smsL240119i.doc)